scispace - formally typeset
S

Samuel Aballéa

Researcher at Aix-Marseille University

Publications -  137
Citations -  1561

Samuel Aballéa is an academic researcher from Aix-Marseille University. The author has contributed to research in topics: Cost effectiveness & Medicine. The author has an hindex of 18, co-authored 123 publications receiving 1148 citations.

Papers
More filters
Journal ArticleDOI

Comparative Efficacy and Safety of Medical Treatments for the Management of Overactive Bladder: A Systematic Literature Review and Mixed Treatment Comparison

TL;DR: It is shown that mirabegron 50 mg was as efficacious as antimuscarinics in reducing the frequency of micturition incontinence and UUI episodes and lower incidence of dry mouth, the most common adverse event reported with antimus carinics and one of the main causes of discontinuation of treatment.
Journal ArticleDOI

Efficacy and Tolerability of Mirabegron Compared with Antimuscarinic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysis.

TL;DR: The relief of key OAB symptoms produced by mirabegron 50mg is significantly better than placebo, and similar to a range of common antimuscarinics, with the benefit of significantly fewer bothersome anticholinergic side effects such as dry mouth.
Journal ArticleDOI

Quality of life is predictive of relapse in schizophrenia

TL;DR: QoL, as assessed by the SF36, is an independent predictor of relapse at a 24-month follow-up in schizophrenia, and may support the development and monitoring of complementary therapeutic approaches, such as ‘recovery-oriented’ combined with traditional mental health cares to prevent relapse.
Journal ArticleDOI

Measuring the health-related quality of life in young children: how far have we come?

TL;DR: There is a need to carry out research to develop theoretical models of HRQoL that are specific to children at different developmental stages in order to evaluate and support new and existing measures for paediatric HRZoL and their use in clinical practice as well as clinical trials.
Journal ArticleDOI

The real-life impact of vaccination on COVID-19 mortality in Europe and Israel.

TL;DR: In this paper, the real-life impact of vaccination on COVID-19 mortality, with adjustment for SARS-CoV-2 variants spread and other factors across Europe and Israel, was estimated.